Latest News about Solid Tumor
Recent news which mentions Solid Tumor
Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial
March 15, 2022
From Benzinga
Adagene's Posts Early Safety, Efficacy Data From Cold Tumors Trial
December 07, 2021
Tickers
ADAG
From Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
From Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
December 02, 2021
Tickers
SQZ
From Benzinga
Mereo BioPharma's Etigilimab/Opdivo Combo Achieves One Complete Response In Cervical Cancer
November 30, 2021
From Benzinga
Adagene Shares Jump After FDA Signs Off ADG116/Keytruda Combo Therapy Trial In Solid Tumors
November 30, 2021
From Benzinga
From Benzinga
Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors
November 15, 2021
From Benzinga
Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
November 12, 2021
Tickers
AGEN
From Benzinga
Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
November 09, 2021
From Benzinga
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
From Benzinga
Repare Therapeutics Reveals Early Efficacy Data From Lead Program In Solid Tumor Setting
October 11, 2021
Tickers
RPTX
From Benzinga
Bicycle Therapeutics Stock Falls After Interim Data Of Toxin Conjugates In Ovarian Cancer Trial
October 07, 2021
Tickers
BCYC
From Benzinga
Why Did Prelude Therapeutics Stock Tumble To 52-Week Low Today?
October 07, 2021
Tickers
PRLD
From Benzinga
Amgen Highlights Lumakras Combination Data From Solid Tumor Trials
October 07, 2021
Tickers
AMGN
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
September 28, 2021
From Benzinga
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Tickers
APRE
From Benzinga
Syros Posts Updated Data From CDK7 Inhibitor In Various Solid Tumor Settings
September 20, 2021
Tickers
SYRS
From Benzinga
TCR2 Therapeutics Stock Plunges On Safety Signals From Gavo-cel Solid Tumor Trial
September 17, 2021
Tickers
TCRR
From Benzinga
NGM Bio Presents Preliminary Data From NGM120 Solid Tumor Trial
September 16, 2021
Tickers
NGM
From Benzinga
Athenex Shares Are Trading Higher On Positive Oral Paclitaxel Data From Solid Tumor Trial
September 16, 2021
From Benzinga
Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial
September 16, 2021
From Benzinga
Adaptimmune Shares Encouraging Data From Solid Tumor Trial
September 13, 2021
Tickers
ADAP
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
